{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:08:04Z","timestamp":1778738884632,"version":"3.51.4"},"reference-count":53,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T00:00:00Z","timestamp":1478822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"EU-International Training Network SEWPROF","award":["317205"],"award-info":[{"award-number":["317205"]}]},{"name":"Norwegian Centre for Addiction Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Wastewater\u2010based epidemiology is an alternative method for estimating the collective drug use in a community. We applied functional data analysis, a statistical framework developed for analysing curve data, to investigate weekly temporal patterns in wastewater measurements of three prescription drugs with known abuse potential: methadone, oxazepam and methylphenidate, comparing them to positive and negative control drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sewage samples were collected in February 2014 from a wastewater treatment plant in Oslo, Norway. The weekly pattern of each drug was extracted by fitting of generalized additive models, using trigonometric functions to model the cyclic behaviour. From the weekly component, the main temporal features were then extracted using functional principal component analysis. Results are presented through the functional principal components (FPCs) and corresponding FPC scores.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Clinically, the most important weekly feature of the wastewater\u2010based epidemiology data was the second FPC, representing the difference between average midweek level and a peak during the weekend, representing possible recreational use of a drug in the weekend. Estimated scores on this FPC indicated recreational use of methylphenidate, with a high weekend peak, but not for methadone and oxazepam.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The functional principal component analysis uncovered clinically important temporal features of the weekly patterns of the use of prescription drugs detected from wastewater analysis. This may be used as a post\u2010marketing surveillance method to monitor prescription drugs with abuse potential. Copyright \u00a9 2016 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.4127","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T17:18:12Z","timestamp":1479143892000},"page":"320-326","source":"Crossref","is-referenced-by-count":4,"title":["Assessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data"],"prefix":"10.1002","volume":"26","author":[{"given":"Stefania","family":"Salvatore","sequence":"first","affiliation":[{"name":"Norwegian Centre for Addiction Research University of Oslo  Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"R\u00f8islien","sequence":"additional","affiliation":[{"name":"Norwegian Centre for Addiction Research University of Oslo  Oslo Norway"},{"name":"Department of Health Studies University of Stavanger  Stavanger Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Baz\u2010Lomba","sequence":"additional","affiliation":[{"name":"Norwegian Centre for Addiction Research University of Oslo  Oslo Norway"},{"name":"Norwegian Institute for Water Research  Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen G.","family":"Bramness","sequence":"additional","affiliation":[{"name":"Norwegian Centre for Addiction Research University of Oslo  Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,11,11]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1532-2149.2013.00374.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302367"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.81"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e3181b26e9f"},{"key":"e_1_2_9_6_1","unstructured":"EMCDDA. Prescription medicines. Secondary Prescription medicines2016.http:\/\/www.emcdda.europa.eu\/best\u2010practice#view\u2010answer19."},{"key":"e_1_2_9_7_1","unstructured":"Food and Administration D.Guidance for industry: assessment of abuse potential of drugs. Center for Drug Evaluation and Research Department of Health and Human Services Washington DC2010."},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-88-470-5322-9_29"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2004.09.004"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-37"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0565-8"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.11022"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.05.007"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2010.12.006"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1039\/c0em00686f"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02678.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2012.02135.x"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.06.007"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2014-051553"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2015.02.002"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1842"},{"key":"e_1_2_9_22_1","first-page":"1","article-title":"Detection of the ethanol consumption markers ethyl glucuronide and ethyl sulfate in urine samples from inmates of two German prisons","author":"Thierauf\u2010Emberger A","year":"2015","journal-title":"International journal of legal medicine"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2014.10.011"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2014.05.064"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2014.01.021"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2013.02.020"},{"key":"e_1_2_9_27_1","doi-asserted-by":"crossref","unstructured":"Baz\u2010LombaJA SalvatoreS Garcia\u2010LorE et al.Comparison of illicit drug pharmaceutical alcohol nicotine and caffeine levels in wastewater with other sources of data for 8 European cities. (submitted)2016.","DOI":"10.1186\/s12889-016-3686-5"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2012.06.069"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138669"},{"key":"e_1_2_9_30_1","first-page":"1","article-title":"A nuanced picture of illicit drug use in 17 Italian cities through functional principal component analysis of temporal wastewater data","author":"Salvatore S","year":"2016","journal-title":"Journal of public health"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-016-0179-2"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.3.297"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00188-6"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2013.11.008"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2013.11.039"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2016.01.056"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2010.05.030"},{"key":"e_1_2_9_38_1","first-page":"153","article-title":"Dealing with Missing Data","volume":"3","author":"Scheffer J","year":"2002","journal-title":"Res Lett Inf Math Sci"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v045.i07"},{"key":"e_1_2_9_40_1","unstructured":"WoodS.Generalized additive models: an introduction with R.Chapman and Hall and CRC Press:Boca Raton FL 2006."},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1109\/TAC.1974.1100705"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech.53.4.235"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv064"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/0470013192.bsa239"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-98185-7"},{"key":"e_1_2_9_46_1","unstructured":"The R Foundation for Statistical Computing: R version 3.2.2 (2015.08.14) [program].http:\/\/www.r\u2010project.org 2015."},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1089\/1044546041649066"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/0960327114543935"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199603000-00017"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(03)00050-0"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac061095b"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7031.629"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-007-9146-7"},{"key":"e_1_2_9_54_1","unstructured":"EMCDDA.Problem amphetamine and methamphetamine use in Europe.2010."}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.4127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.4127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:25:32Z","timestamp":1696508732000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.4127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,11]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1002\/pds.4127"],"URL":"https:\/\/doi.org\/10.1002\/pds.4127","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,11]]}}}